In this study, the effect of pharmaceutical-grade alginates on the cell viability of human mesenchymal stem cells derived from umbilical cord was examined and their use in tissue engineering applications was evaluated. The effects of the ratio of the copolymer building blocks (guluronic and mannuronic acids) and their interactions with divalent calcium, the purity of alginates (proteins and polyphenol content), and gelation factors (calcium concentration and sol content) were examined. The high guluronic acid content in the alginates improved the viability of the human mesenchymal stem cells derived from umbilical cord and supported cell growth significantly. It was confirmed that the sol fraction of alginate reduced cell viability. Cells in the presence of alginate beads cross-linked with 50 and 100 mM calcium chloride showed maximum viability; the protein and polyphenol content of the alginates did not affect the viability of the human mesenchymal stem cells derived from umbilical cord, while the monomer ratio did have an obvious effect.
Code of federal regulations title 21. Department of Health and Human Services, Chapter I, subchapter H, part 872, section 3660.
5.
WeeSGombotzWR. Protein release from alginate matrices. Adv Drug Deliver Rev1998; 31(3): 267–285.
6.
NilssonKBrodeliusPMosbachK. Entrapment of microbial and plant cells in beaded polymers. Method Enzymol1987; 135: 222–230.
7.
SmidsrodOSkjak-BraekG. Alginate as immobilization matrix for cells. Trends Biotechnol1990; 8(3): 71–78.
8.
EiseltPYehJLatvalaRKSheaLDMooneyDJ. Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials2000; 21(19): 1921–1927.
9.
WangYKimUJBlasioliDJKimHJKaplanDL. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials2005; 26(34): 7082–7094.
10.
ReesDA. Structure confirmation and mechanism in the formation of polysaccharide gels and networks. In: WolffromML TipsonRS (eds) Advances in carbohydrate chemistry and biochemistry. New York: Academic Press, 1969, Vol. 24, pp.267–332.
11.
GrantGTMReesERSmithDA. Biological interactions between polysaccharides and divalent cations: the egg box model. FEBS Lett1973; 32: 195–198.
12.
Soon-ShiongPFeldmanENelsonR. Long-term reversal of diabetes in the large animal model by encapsulated islet transplantation. Transplant Proc1992; 24(6): 2946–2947.
13.
StablerCWilksKSambanisAConstantinidisI. The effects of alginate composition on encapsulated betaTC3 cells. Biomaterials2001; 22(11): 1301–1310.
14.
VeriterSMergenJGoebbelsRM. In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation. Tissue Eng Pt A2010; 16(5): 1503–1513.
15.
KlockGFrankHHoubenR. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol1994; 40(5): 638–643.
16.
OriveGHernándezRMGascónARIqartuaMPedrazJL. Encapsulated cell technology: from research to market. Trends Biotechnol2002; 20(9): 382–387.
17.
DusseaultJTamSKMénardM. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J Biomed Mater Res A2006; 76(2): 243–251.
18.
DånmarkSFinne-WistrandAWendelM. Osteogenic differentiation by rat bone marrow stromal cells on customized biodegradable polymer scaffolds. J Bioact Compat Polym2010; 25: 207–223.
19.
SongWLuHKawazoeNChenG. Gradient patterning and differentiation of mesenchymal stem cells on micropatterned polymer surface. J Bioact Compat Polym2011; 26: 242–256.
20.
KarahuseyinogluSCinarOKilicE. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells2007; 25(2): 319–331.
21.
MosmannT. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods1983; 65(1–2): 55–63.
22.
TungYTWuJHKuoYHChangST. Antioxidant activities of natural phenolic compounds from Acacia confusa bark. Bioresour Technol2007; 98(5): 1120–1123.
23.
OmidianHRoccaJGParkK. Elastic, superporous hydrogel hybrids of polyacrylamide and sodium alginate. Macromol Biosci2006; 6(9): 703–710.
24.
SimpsonNEStablerCLSimpsonCPSambanisAConstantindisI. The role of the CaCl2-guluronic acid interaction on alginate encapsulated betaTC3 cells. Biomaterials2004; 25(13): 2603–2610.
25.
BarraletJEWangLLawsonMTriffittJTCooperPRSheltonRM. Comparison of bone marrow cell growth on 2D and 3D alginate hydrogels. J Mater Sci-Mater Med2005; 16(6): 515–519.
26.
KierstanMDarcyGReillyJ. Studies on the characteristics of alginate gels in relation to their use in separation and immobilized applications. Biotechnol Bioeng1982; 24(7): 1507–1517.
27.
WangLSheltonaRMCooperPR. Evaluation of sodium alginate for bone marrow cell tissue engineering. Biomaterials2003; 24(20): 3475–3481.
28.
TamSKBilodeauSDusseaultJLangloisGHalleJPYahiaLHBiocompatibility and physicochemical characteristics of alginate-polycation microcapsules. Acta Biomater2011; 7(4): 1683–1692.
29.
TamSKDusseaultJBilodeauSLangloisGHalleJPYahiaL. Factors influencing alginate gel biocompatibility. J Biomed Mater Res A2011; 98(1): 40–52.
30.
PetruzzoPCappaiARuiuGDessyERescignoABrotzuG. Development of biocompatible barium alginate microcapsules. Transplant Proc1997; 29(4): 2129–2130.
31.
SchneiderSFeilenPJKrausO. Biocompatibility of alginates for grafting: impact of alginate molecular weight. Artif Cells Blood Substit Immobil Biotechnol2003; 31(4): 383–394.
32.
ZimmermannUThürmerFJorkA. A novel class of amitogenic alginate microcapsules for long-term immunoisolated transplantation. Ann N Y Acad Sci2001; 944: 199–215.
33.
JorkAThurmerFCramerH. Biocompatible alginate from freshly collected Laminaria pallida for implantation. Appl Microbiol Biotechnol2000; 53(2): 224–229.
34.
ClaytonHALondonNJCollobyPSBellPRJamesRF. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules. J Microencapsul1991; 8(2): 221–233.
35.
De VosPDe HaanBJWoltersGHStrubbeJHSchilfgaardeR. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia1997; 40(3): 262–270.
36.
KlockGPfeffermannARyserC. Biocompatibility of mannuronic acid-rich alginates. Biomaterials1997; 18(10): 707–713.
37.
ZhangWJLaueCHyderASchrezenmeirJ. Purity of alginate affects the viability and fibrotic overgrowth of encapsulated porcine islet xenografts. Transplant Proc2001; 33(7–8): 3517–3519.
38.
BerridgeMJLippPBootmanMD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol2000; 1(1): 11–21.
39.
HajnoczkyGDaviesEMadeshM. Calcium signaling and apoptosis. Biochem Biophys Res Commun2003; 304(3): 445–454.
40.
OrreniusSZhivotovskyBNicoteraP. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol2003; 4(7): 552–565.
